In other clinical trials, NRF2 hyperactivation has been linked to the development of bone hypoplasia [58], hydronephrosis [59], esophagus, and forestomach hyperkeratosis [60], altered mitochondrial bioenergetics, hallmark features of type 1 diabetes, and accelerated aging [61]. This evidence concerns the gene NFE2L2 and hydronephrosis.